Is the National Veterinary Care Ltd (ASX:NVL) share price a buy after increasing its debt facilities?

The National Veterinary Care Ltd (ASX:NVL) share price rose today after announcing increased debt facilities.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The National Veterinary Care Ltd (ASX: NVL) share price rose 2.7% today after the company announced that it has increased its debt facilities.

National Vet Care has arranged its new facility arrangements with the company's existing financier Australia and New Zealand Banking Group (ASX: ANZ).

There is an increase of $19 million in the term loan facility to $61 million.

There was an increase of $0.75 million in the working capital facility, which incorporates the bank guarantee and overdraft sub-facilities to $3.5 million and a new facility term of three years which expires in June 2021.

The actual terms of the facilities are similar to the old facility's terms.

Managing Director Tomas Steenackers said "We are delighted that we continue to receive strong support for our business model and growth strategy from our financiers, who we have worked with since inception of the business three years ago.

"The increase in facilities and term extension provides National Vet Care with significant capacity to support our forecast growth and strong FY19 acquisition pipeline."

Is National Vet Care a buy?

I think it's one of the most promising small caps on the market. It has been steadily acquiring clinics, which means that it has a lot of annualised revenue (and profit) that won't be fully realised until the FY19 result.

The pet industry has a lot of likeable factors including defensive earnings, recurring earnings due to annual pet visits, National Vet Care has a strong pet membership program and it is generating organic revenue growth of 3%.

National Vet Care is trading at around 24x FY18's estimated earnings. I'd be happy to buy some shares at the current price.

Motley Fool contributor Tristan Harrison owns shares of NATVETCARE FPO. The Motley Fool Australia owns shares of NATVETCARE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »